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Transmembrane peptidesTrichogin GA IV (GAIV) is an antimicrobial peptide of the peptaibol family, like the extensively studied
alamethicin (Alm). GAIV acts by perturbing membrane permeability. Previous data have shown that pore for-
mation is related to GAIV aggregation and insertion in the hydrophobic core of the membrane. This behavior
is similar to that of Alm and in agreement with a barrel-stave mechanism, in which transmembrane oriented
peptides aggregate to form a channel. However, while the 19-amino acid long Alm has a length comparable
to the membrane thickness, GAIV comprises only 10 amino acids, and its helix is about half the normal bilayer
thickness. Here, we report the results of neutron reﬂectivity measurements, showing that GAIV inserts in the
hydrophobic region of the membrane, causing a signiﬁcant thinning of the bilayer. Molecular dynamics sim-
ulations of GAIV/membrane systems were also performed. For these studies we developed a novel approach
for constructing the initial conﬁguration, by embedding the short peptide in the hydrophobic core of the
bilayer. These calculations indicated that in the transmembrane orientation GAIV interacts strongly with
the polar phospholipid headgroups, drawing them towards its N- and C-termini, inducing membrane thin-
ning and becoming able to span the bilayer. Finally, vesicle leakage experiments demonstrated that GAIV
activity is signiﬁcantly higher with thinner membranes, becoming similar to that of Alm when the bilayer
thickness is comparable to its size. Overall, these data indicate that a barrel-stave mechanism of pore forma-
tion might be possible for GAIV and for similarly short peptaibols despite their relatively small size.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are produced by all organisms as a
ﬁrst defense against pathogens. They exhibit multiple roles, including
chemotactic and immunomodulatory functions [1], but their main ac-
tivity is bactericidal, often through the perturbation of the permeabilityanol; Aib, α-aminoisobutyric
CF, carboxyﬂuorescein; DIEA,
amide; EDC, N-ethyl, N′-[3-
l-9-methyloxycarbonyl; GAIV,
tetramethyluronium hexaﬂuoro
cinol; MD, molecular dynamics;
phosphocholine; SLD, scattering
ecnologie Chimiche, Università
Rome, Italy. Tel.:+39067259
rights reserved.of bacterial membranes [2]. This mechanism of actionmakes the devel-
opment of bacterial resistance particularly unlikely. It is for this reason
that AMPs are investigated as a possible solution to the dramatic health
problem of multiple drug-resistant bacteria [3]. However, in order to
develop newmolecules with the same activity as AMPs, but with better
drug-like properties [4,5], it is essential to understand their mechanism
of pore formation in detail.
Most AMPs are cationic [6] and perturb membrane permeability
according to the Shai–Matsuzaki–Huang (SMH) model [7–10]. They
bind to the membrane surface, parallel to it, thus modifying its sur-
face tension and eventually leading to the formation of local bilayer
defects that allow the passage of hydrophilic and charged molecules.
Another class of pore-forming, bactericidal peptides, whichwas actu-
ally discovered well before cationic AMPs, is represented by peptaibols,
or peptaibiotics [11]. These peptides are produced non-ribosomally by
fungi, are characterized by a C-terminal 1,2-amino alcohol and a high
content of non proteinogenic residues, most notably α-aminoisobutyric
acid (Aib), and are usually acetylated or acylated at the N-terminus.
Peptaibiotics are usually helical both in solution and when membrane-
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very low or even absent altogether. The best characterized member of
this family (and the second to be identiﬁed, in 1967) is alamethicin
(Alm) [12]. For this peptide it has been conclusively demonstrated
through a combination of a large set of biophysical techniques that
it forms pores through a mechanism different from the SMH model,
and termed “barrel-stave” [13–20]. In this case, equilibria between
different peptide alignments in the bilayer exist [21,22], but when the
membrane-bound peptide concentration is sufﬁciently high and/or a
transbilayer potential is applied, peptide helices insert in a transmem-
brane orientation and aggregate in a cylindrical superstructure, like the
staves in a barrel, with the more hydrophilic side of the helices facing
the water-ﬁlled channel lumen. This model was ﬁrst proposed in 1974,
but until now it has been convincingly demonstrated only for Alm.
Alm comprises 19 amino acids and its helix has a length corre-
sponding almost exactly to the thickness of biological membranes
(Fig. 1). However, it is also one of the longest members of the
peptaibiotic family, which contains peptides going from 21 amino
acids (SCH 643432) to just 4 (peptaibolin) [11]. Considering the
closely related amino acid composition and physico-chemical proper-
ties of all members of the peptaibiotic family, it is conceivable that
they could form pores in a similar way. However, an important draw-
back seems to preclude the formation of transmembrane pores to
shorter peptides: how could such short helices form channels span-
ning through the whole bilayer?
A well characterized, medium-length peptaibiotic is trichogin GA IV
(GAIV henceforth), whose sequence is nOct-Aib1-Gly2-Leu3-Aib4-Gly5-
Gly6-Leu7-Aib8-Gly9-Ile10-Lol, where nOct is n-octanoyl, and Lol is
leucinol [23]. This 10-mer peptide was isolated from Trichoderma
longibrachiatum in 1992 [24] and since then it was studied both in solu-
tion and in model membranes by a number of physico-chemical tech-
niques [25], including NMR [24,26], X-ray crystallography [27], EPR
[28–33], ﬂuorescence [34–40], electrochemistry [41,42], and molecular
dynamics simulations [10]. Its 3D-structure is helical, with a ﬂexible
hinge in the central part, formed by two consecutive Gly residues
[24,27,37,38]. In this conformation, its length is only about half the
normal thickness of a biological membrane (Fig. 1). For this reason, dif-
ferent models were proposed to explain its pore-forming activity, in-
cluding the SMH mechanism [26,28,43] and a carrier function [29,30].
However, several evidences would favor a barrel-stave structure forFig. 1. Comparison of the length of the Alm and GAIV helices with the thickness of a
POPC bilayer. Phosphorus, nitrogen and oxygen atoms of phospholipids are shown as
gold, blue and red spheres, respectively, while water oxygen atoms are colored in
pink. The acyl chains of the phospholipids are omitted for the sake of clarity. Peptides
are represented as ribbons. The N-terminal acyl and C-terminal amino alcohol groups
are shown in a “stick” representation.its pores, just like Alm. In this connection, by combining several differ-
ent ﬂuorescence experiments we showed that, above a threshold
concentration, GAIV inserts deeply into the hydrophobic core of the
membrane and forms aggregates. These inserted, aggregated species
are responsible for membrane leakage [34–36]. Later on, these ﬁndings
were conﬁrmed by EPR measurements [31–33]. Other studies estab-
lished that GAIV-induced membrane permeability is ion-selective and
depends on the sign andmagnitude of the transmembrane potential, ex-
actly like that of Alm channels [41,42,44].
One hypothesis that was put forward to solve the apparent contra-
diction between these data and the short length of the GAIV helix is for-
mation of head-to-head dimers able to span the entire bilayer [27,32].
However, this hypothesis seems not to be supported by the voltage
dependence of GAIV-induced membrane permeability, which would
require a co-linear alignment of the helices forming the channel, to gen-
erate an overall dipole that could sense the transbilayer potential [44].
In a previous study [10], we investigated GAIV location inside a
lipid bilayer by molecular dynamics (MD) simulations using a self-
assembling approach [45,46] that we deﬁned as “minimum bias”
[47,48]. In this method, the simulation starts from a random mixture
of lipids and water, containing one peptide molecule. During the sim-
ulation, a lipid bilayer self-assembles spontaneously, but in the ini-
tially highly ﬂuid environment the peptide is able to attain its most
favorable position in the membrane. This study [10] indicated a pos-
sible solution to the problem of the mismatch between membrane
thickness and peptide length. In two out of three such simulations
with GAIV, the peptide positioned close to the membrane surface,
parallel to it, without signiﬁcantly perturbing the membrane. How-
ever, in a third simulation it inserted into the bilayer in a transmem-
brane orientation. This simulation showed a bilayer that, near the
peptide, was signiﬁcantly thinned, so that the short GAIV helix was
able to span completely the membrane. Nevertheless, this prelimi-
nary result could not rule out the possibility that the observed effect
was an artifact of the way the bilayer formed, since in this simulation
GAIV was initially inserted in a local defect of the membrane, which
healed only after an extensive simulation. The short length of the
equilibrated segment of that simulation (10 ns) left open the possi-
bility that the observed bilayer structure was just a transient, meta-
stable state, which would eventually relax. More importantly, this
purely computational but intriguing indication needed an experimen-
tal veriﬁcation.
Here, we report combined experimental and simulative data sup-
porting the possibility for GAIV to form barrel-stave channels. Neutron
reﬂectivity studies were used to experimentally verify the effects of
GAIV on bilayer thickness. Moreover, vesicle leakage experiments
were exploited to determine the inﬂuence of membrane thickness on
GAIV activity. In addition, our previous MD simulation studies were
signiﬁcantly extended, to conﬁrm the stability of the transmembrane
orientation, even when starting from a preformed bilayer, and to verify
the cumulative effects of multiple membrane-inserted peptide chains.
Overall, these data indicate that GAIV might be able to form barrel-
stave channels by causing a signiﬁcant thinning of the bilayer to a thick-
ness comparable with the length of its helix.
2. Materials and methods
2.1. Materials
All phospholipidswere purchased fromAvanti Polar Lipids (Alabaster,
AL, USA). Spectroscopic grade organic solvents were obtained from Carlo
Erba Reagenti (Milano, Italy). Carboxyﬂuorescein (CF), Triton-X 100, and
Sephadex-G50 were Sigma Aldrich (St. Louis, MO) products. Fmoc-Aib-
OH (Fmoc, ﬂuorenyl-9-methyloxycarbonyl) and Fmoc-Gly-OH were
supplied from Novabiochem (Merck Biosciences, La Jolla, CA). N,
N-dimethylformamide (DMF), N,N-diisopropylethylamine (DIEA), piper-
idine, N-methylmorpholine, 1,1,1,3,3,3-hexaﬂuoroisopropanol (HFIP),
Table 1
Available datasets.
Lipids Peptide Concentration D2O SMW H2O
POPC – C0 X X X
(d31)POPC – C0 X X X
POPC Deuterated C1 X X
POPC Deuterated C2 X X
POPC Deuterated C3 X X
(d31)POPC Hydrogenated C1 X X
(d31)POPC Hydrogenated C2 X X
(d31)POPC Hydrogenated C3 X X
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(St. Louis, MO). N-Ethyl, N′-[3-(dimethylamino)propyl]carbodiimide
(EDC), O-(7-azabenzotriazol-1-yl)-1,1,3,3 tetramethyluronium hexa-
ﬂuorophosphate (HATU), and 7-aza-1-hydroxy-benzotriazole (HOAt)
were purchased from GLS (Shangai, China). n-Octanoic (nOct) acid-d15,
L-leucine-d10, and L-isoleucine-d10 were purchased from Euriso-top
(Saint-Aubin, France).
2.2. Peptide synthesis and characterization
Native GAIV was synthesized as previously reported [49]. Fmoc-
protection of deuterated residues was achieved by reaction with 1.2
equivalents of Fmoc-OSu and 1 equivalent of triethylamine in
water/CH3CN. Yield: 70%. A GAIV analogue deuterated on the Leu
and Ile residues, and on n-octanoyl, was synthesized by manual solid
phase peptide synthesis on a 0.05 mmol scale, starting with L-leucinol
2-chlorotrityl resin (Iris Biotech, Marktredwitz, Germany) (110 mg, load-
ing 0.45 mmol g−1). Fmoc-deprotection was performed with a 20%
piperidine solution in DMF (reaction time: 5 min, repeated twice). The
coupling steps, carried out in presence of HATU and DIEA, were doubled
and followed by a capping protocol using acetic anhydride in a large
excess. The nOct moiety at the N-terminus was added by reaction
with the preformed activated ester of nOct-OH, obtained by reaction
with an equivalent amount of EDC and HOAt in the presence of
N-methylmorpholine. The 1-hour coupling procedure was repeated
twice. Peptide cleavage from the resin was achieved by treatment
with 30% HFIP in dichloromethane. The ﬁltrate was collected and this
step repeated three times (the last one was performed overnight). Then,
the solution was concentrated under a ﬂow of N2. The crude peptide
was puriﬁed by preparative HPLC on a Phenomenex C18 column
(30×250 mm, particle size: 5 μm, pore size: 300 Å), using a Shimadzu
(Kyoto, Japan) LC-8A pump system equipped with a SPD-6A UV-
detector (ﬂow rate 15 mL/min, λ=216 nm) and a binary elution
system: A, H2O; B, CH3CN/H2O (9:1 v/v); gradient 40%–70% B in
30 min. The puriﬁed fraction was characterized by analytical RP-HPLC
on a Vydac C18 column (4.6×250 mm, 5 μm, 300 Å) using a Dionex
(Sunnyvale, CA) P680 HPLC pump with an ASI-100 automated sample
injector. The binary elution systemusedwas: A, 0.1% TFA (triﬂuoroacetic
acid) in H2O; B, 0.1% TFA in CH3CN/H2O (9:1 v/v); gradient 60%–80% B
in 20 min (ﬂow rate 1.5 mL min−1); spectrophotometric detection at
λ=216 nm. Retention time: 14.3 min. Yield after puriﬁcation: 50%.
Purity>97%. Electrospray ionization (ESI)-MS was performed on a
PerSeptive Biosystem Mariner instrument (Framingham, MA). (m/z):
calculated for C52H50N11O12D45 [M+H]+ 1112.01; found 1111.98.
2.3. Neutron Reﬂectometry (NR) experiments
Silicon single crystals (5×5×1 cm3) cut along the (111) planewere
cleaned by rinsing, under sonication, in chloroform, acetone, and etha-
nol. A 30 min UV/ozone treatment was used to make the polished sur-
face more hydrophilic. Sample holders were laminar ﬂow cells that
allowed the injection of lipids and peptides and the exchange of the
solvent to apply the well known contrast variation method [50]. To
this aim, high purity D2O (ILL) andMilli-Qwaterwere usedwith the fol-
lowing ratios 1:0, 0:1 or 38:62 (for silicon-matched water or SMW) in
order to obtain media with scattering length density (SLD or ρ)
6.35×10−6 Å−2, −0.56×10−6 Å−2 and 2.07×10−6 Å−2, respective-
ly. Neutron reﬂectivity experiments were performed at the silicon/
water interface on the D17 reﬂectometer at ILL [51]. Specular neutron
reﬂection gives information about the thickness and the compositional
proﬁle of a ﬁlm along the direction normal to its surface (z). The overall
process can be described by the classical theory of reﬂection of light,
with a neutron refractive index n≈1− λ
2
0ρ
2π , where λ0 is the incident
wavelength and ρ the scattering length density. The latter parameter
is directly related to the nuclear composition of the sample and changes
upon isotopic substitution [52]. Neutron reﬂectivity data are measuredas the ratio of intensities of the reﬂected and incident beams (R= I/I0),
as a function of the wave-vector transfer in the perpendicular direction
to the layers interface Qz. For a given incident wavelength λ0 and angle
αi it is expressed as Q z ¼ 4πλ0 sinαi. In our case, time-of-ﬂight measure-
ments were performed using wavelengths λ0 in the range 2 to 18 Å to-
gether with two different angular conﬁgurations resulting in a covered
Qz going from 0.005 to 0.3 Å−1.
Two silicon monocrystalline solid supports were used and charac-
terized before the injection of lipid vesicles. Solid supported POPC
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and (d31)POPC
lipid bilayers were obtained by the vesicle fusion method, which
relies on spontaneous adhesion of the lipids to the surface following
a vesicles spreading process [53]. Small unilamellar vesicles were
formed by evaporating a chloroform lipid solution in a rotary vacuum
system until a thin ﬁlm was formed. Complete evaporation was
ensured by applying a rotary vacuum pump for at least 2 h. Subse-
quently, the ﬁlm was hydrated with phosphate buffer 10 mM, NaCl
140 mM, pH 7.4, for a ﬁnal lipid concentration of 0.5 mg/mL. The ves-
icle suspension was sonicated by immersion of a titanium tip for
three periods 10 min long at a power of 70 W, with suitable pauses
between them to avoid excessive sample heating. Five milliliters of
the vesicle suspension were injected in the sample ﬂow cell. Excess
of lipids not bound to the surface was removed by ﬂushing water in
the ﬂow cell. To enhance the signal arising from the peptide mole-
cules, addition of partially deuterated GAIV was used in combination
with hydrogenated POPC, while hydrogenous peptides were added to
the partially deuterated lipid bilayer. Four different concentrations of
peptide were used, namely C0 (bare lipid bilayer), C1 (4.5 μM), C2
(15 μM), and C3 (30 μM). All of the peptide–lipids–solvent combina-
tions exploited are reported in Table 1.
2.4. NR data analysis
The measured specular reﬂectivity data are connected to the ar-
rangement of the material within the sample along the normal to
the deposition interface. The relation can be summarized by the mas-
ter formula [54]
R Qzð Þ ¼
16π2
Q4z
∫ dρ zð Þ
dz
eiQzzdz








2
ð1Þ
where the compositional information is described by the SLD along
the z direction, ρ(z).
A limitation in the analysis of NR data is the impossibility of a direct
Fourier transform of the reﬂectivity R(Qz) that would result in the SLD
proﬁle, as evident from Eq. (1). This limitation, known as phase-loss
problem, can be overcome using the contrast variation method, i.e.
modeling data originated from the same sample with different isotopic
substitutions. The more are the contrasts available, the higher is the ac-
curacy in the data modeling. For example, in the present experiment,
all of the data available for a given concentration (Table 1) were
modeled simultaneously to exploit this peculiarity of NR.
The data ﬁtting procedure was based on the Parratt's recursion re-
lation [55], originally derived for reﬂection of X-rays but nowadays
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the data was performed using an homemade software written in
Matlab. The minimization routine was Fminuit, a χ2 ﬁtting program
for Matlab based on the MINUIT minimization engine of the CERN
program library [56]. The system was modeled as a stack of four
layers, each of them described by a triplet of parameters [thickness
t, ρ(fk) and interfacial roughness σ]. The parameter fk is the volume
fraction of the k component within the selected layer (Eq. (2)).
The ﬁrst layer was used to describe the SiO2 layer together with its
hydrationwater. The sets of parameters, for both blocks, were obtained
during the preliminary characterization of the bare silicon supports and
kept ﬁxed during the subsequent analysis. The remaining layers were
respectively used tomodel: (i) the inner hydrophilic headgroup region,
(ii) the hydrophobic tail region and (iii) the outer headgroup layer. All
of the information available about the sample components was intro-
duced in the model as constraints. These values are summarized in
Table S1 of the supporting materials.
If the composition of a layer is not uniform, i.e. in presence of more
than one component, the SLD representing the layer can be expressed
as a linear combination of the SLDs of the components, where the
weighting factors are the component volume fractions. In general,
for the i-th layer the SLD was expressed as
ρi ¼ f iρdryi þ f iwρw þ f ipρdryp ð2Þ
where f i, fw i, and fpi are respectively the volume fractions of the lipid,
water, and peptide components in the i-th layer, and their sum is nor-
malized to unity.
2.5. Set-up of MD simulations
The GAIV X-ray diffraction determined structure [27] was used as
the initial peptide conformation. The initial lipid bilayer structure for
the simulations was downloaded from http://moose.bio.ucalgary.ca/
download.html [57], and comprised 128 POPC lipids (64 per leaﬂet)
and 2460 water molecules. 3102 additional water molecules were
then added, to enable larger distances between the periodic images
of the lipid leaﬂets in the direction perpendicular to the lipid/water
interface. This system was equilibrated for 5 ns and simulated for fur-
ther 15 ns, for comparison with peptide-containing membranes. The
equilibrated bilayer was taken as the starting point for the simula-
tions in the presence of GAIV. In the bilayer we inserted 1, 4 or
8 GAIV molecules, following the protocol described in the next para-
graph. For the systems with 4 and 8 peptides, three independent sim-
ulations were performed starting from the conﬁgurations reported in
Fig. S1. In all cases, both possible helix orientations with respect to the
bilayer normal were included, with the nearest neighbor peptide
molecules oriented in an antiparallel arrangement. However, while
in the simulations with 4 GAIV molecules the peptide helices were
relatively close to each other and oriented with the hydrophilic re-
gions facing each other, the simulations with 8 molecules started
from a periodic arrangement, to reproduce a hexagonal lattice, with
the peptides as far as possible and with the same azimuthal orienta-
tion (Fig. S1).
2.6. Protocol for peptide insertion in the membrane
To insert the GAIV molecules into the bilayer, we developed a novel
method to create in themembrane cavities of shape anddimensions cor-
responding to those of the peptide. This protocol is based on a gradual
switching of a repulsive potential in the positions to be occupied by the
peptide atoms, in order to push the lipid chains out of that volume, tak-
ing advantage of their intrinsic ﬂexibility. The peptide atoms (excluding
hydrogens) were treated as isolated dummy atoms with the van der
Waals properties of the CH3 atom type in the ffgmx force-ﬁeld [58], as
implemented in GROMACS [59]. These dummies were inserted in thefully hydrated bilayer, in the position to be eventually occupied by the
peptides, with all their interactions initially switched off. Their van der
Waals potential was then gradually and continuously increased up to
its force-ﬁeld value during a 50 ps stochastic dynamics simulation, in
which the dummy atoms were position restrained with a harmonic po-
tential with a force constant of 105 KJ mol−1 nm−2. Note that in princi-
ple the speciﬁc atom types could be used, rather than treating all heavy
atoms as CH3. However, considering thatwehad simply to create a cavity
of appropriate dimension and form, the adopted procedure is adequate
and deﬁnitively simpler. The van derWaals interactions were calculated
by using a soft core potential, as implemented in GROMACS [60], with a
switch function between 0.8 and 0.9 nm; the α scaling factor and the
power for λ in the “soft-core” potential were 0.5 and 1, respectively. To
carry out the stochastic dynamics simulation, we adapted a standard
procedure, usually adopted for free-energy calculations [http://www.
bevanlab.biochem.vt.edu/Pages/Personal/justin/gmx-tutorials/free_
energy/Files/nvt.mdp]. With respect to the conditions reported on that
site, we adopted a linear variation for the λ parameters (Δλ=10−5),
reduced the time step to 0.5 fs, and introduced a semi-isotropic
Berendsen pressure coupling [61], with a reference pressure of 1 atm
and a coupling time constant of 5 ps. During these simulations the in-
teraction between dummy atomswere turned off, and bond constraints
were not used. All of the MD simulations were performed using the
freely available GROMACS 4.0.7 software package, without further
modiﬁcations [59]. An image of the cavity formation process is shown
in Fig. S2. After cavity formation the correct peptide atoms were
substituted for the dummy atoms, and the system was equilibrated by
an energy-minimization step and a ﬁrst 10 ns MD run with position-
restraining on the peptides.
2.7. MD trajectories calculation and analysis
The systems were simulated for 100 ns, adopting the conditions
previously described [10,47], except that in the present study semi-
isotropic pressure coupling was used. Molecular graphics were
obtained with the program VMD (Visual Molecular Dynamics) [62].
SLD proﬁles were calculated from the last 10 ns of the MD simula-
tions, as follows: the density proﬁle along the axis normal to the
bilayer was calculated for each element of the system by using the
g_density utility of the GROMACS package. These density values were
multiplied by the coherent scattering length of the corresponding ele-
ment [52], and then summed together to obtain the overall SLD.
When multiple simulations were performed at the same peptide/lipid
ratio, the SLD proﬁles were averaged over all available trajectories.
These calculated SLD proﬁles cannot be compared directly to the exper-
imental ones, since the latter have silicon on one side of themembrane,
while in the simulations the bilayer faced a water phase on both sides.
To overcome this issue, the experimental proﬁles were made symmet-
rical by reﬂecting the water-facing side with respect to the center of
the hydrophobic region.
Order parameters for the for the C\C bonds of the palmitic chains
were calculated with respect to the bilayer normal, according to stan-
dard deﬁnitions [10,59], on the last 10 ns of the trajectories.
2.8. Membrane-perturbing activity experiments
For CF leakage experiments, vesicles were prepared by dissolving
the lipids in a 1:1 methanol–chloroform mixture, and evaporating
the solvent in a rotary vacuum system and then applying a rotary
vacuum pump for at least 2 h. Subsequently, the ﬁlm was hydrated
with a 30 mM CF solution, prepared in 10 mM phosphate buffer,
pH 7.4, titrated with 85 mM NaOH to make CF water-soluble, and
containing 80 mM NaCl to make it isotonic to the dilution buffer
(phosphate buffer 10 mM, NaCl 140 mM, pH 7.4, 270 mOsm).
The peptide was added to a 200 μM solution of 200 nm CF
loaded-liposomes, prepared with lipids of different tail lengths. The CF
Fig. 2. A) Neutron reﬂectivity proﬁles for the POPC bilayer in D2O, in the absence of
GAIV (violet), and after addition of deuterated GAIV, at concentrations C1 (blue), C2
(green) and C3 (red). B) Neutron scattering length density (SLD) proﬁles for the
POPC-based samples at different deuterated peptide concentrations in D2O (the color
code is the same as that in panel A). The thinning of the hydrophobic region upon pep-
tide addition is clearly visible. Also the increase of the amount of the included peptide
within this region is indicated by the increase in the scattering length density between
25 Å and 45 Å.
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The fraction of peptide-induced leakage was determined 20 min after
peptide addition to the liposomes solution by following the increase
in the ﬂuorescence signal. The value corresponding to total leakage
(for signal normalization) was obtained by adding 1 mM Triton X-100
[35].
3. Results
3.1. Neutron reﬂectivity experiments
In order to experimentally assess GAIV association with a lipid bilayer
and its effects onmembrane structure, we performed neutron reﬂectivity
experiments on a planar POPC bilayer supported by a silicon crystal and
submerged in a water phase, to which increasing GAIV concentrations
were added. Deuterated peptide, lipids andwater were used in appropri-
ate combinations to increase the reﬂectivity contrast (Table 1). Datawere
analyzed globally (Section 2).
3.2. Bare substrates
Two different Si substrated were used for the POPC and (d31)POPC
bilayers. Beforemembrane deposition, these substrates were character-
ized using three differentwater compositions (Table 1). For that used in
combinationwith hydrogenated POPC, the dioxide layer was character-
ized by a thickness tox=15.8±0.1 Å, a volume fraction of hydrating
water fox=0.15±0.05 and a roughness σ=2.2±0.2 Å. The block
used for supporting deuterated lipids was characterized by the param-
eters tox=15.5±0.1 Å, fox=0.12±0.05, and σ=2.4±0.3 Å. These
values were kept ﬁxed during the modeling of the sample data.
3.3. Bare POPC bilayer
The simultaneous ﬁts on all of the available datasets for a pure lipid
bilayer are shown in Fig. S3. The parameters obtained are in complete
agreement with those already reported in the literature [63]. In both
cases, the parameters of the pure lipid bilayer were indicative of a sym-
metric bilayer, with a total thickness of 48±3 Å. The inner and outer
headgroup regions were 10 Å thick (th=10±1 Å), with a volume frac-
tion of water fh=0.5±0.1. The hydrophobic core of the bilayer was
28 Å thick (2× tt=28±1 Å) with no water penetration, which sug-
gests an almost perfect coverage of the substrate surface [64]. The
roughness of all interfaces was similar and close to 2 Å. From these
values the SLD proﬁles along the normal of the bilayer were evaluated.
They are represented in Fig. S3.
3.4. Peptide effects
The same approach was used for the samples where the peptide
was injected (at concentrations C1, C2, and C3 corresponding to 4.5,
15, and 30 μM, respectively). A qualitative assessment of the experi-
mental data indicated already that structural modiﬁcations induced
by the peptide were taking place in the lipid bilayer.
In Fig. 2 the curves of the POPC bilayer in D2O at the different con-
centrations of deuterated peptide investigated are compared. Two
main features are visible. From the pure lipid bilayer to the C3 sample
a decrease in reﬂectivity in the mid-Q region (0.05–0.15 Å−1) is ob-
served that could be interpreted as a change of contrast between
the sample and the solvent. Indeed, according to Eq. (2), addition of
deuterated peptide molecules into a hydrogenated bilayer would
lead to a total SLD closer to that of D2O. It has to be reminded that
the contrast is the difference between the SLD of the sample and
that of the medium. The lower is this value, the weaker is the reﬂec-
tivity (or scattering) signal.
The second feature clearly visible is a shift of the main minimum
of the proﬁles towards higher Qz values. For the pure POPC bilayer itwas located around Qz=0.20 Å−1 and it shifted to higher values
after peptide insertion. This is a clear indication of thinning of the
overall thickness of the deposition.
From the simultaneous ﬁts according to the Parrat's recursive for-
mula, the sample at the four different peptide concentrations was
characterized in a clear and unambiguous way. The resulting param-
eters are listed in Table 2. From these parameters we were able to de-
termine the main structural changes induced by the peptide inclusion
into the lipid bilayer. First of all, the peptide is present only in the hy-
drophobic layer, as described by the volume fractions fph and fpt,
representing the volume fraction of peptide molecules occurring in
the headgroup and tail regions, respectively. fph is zero for all of the
investigated samples. Instead, the quantity of peptide inserting into
Table 2
Parameters obtained from the ﬁts of the data of the lipid–peptide systems at the four
concentrations.
C0 C1 C2 C3
th (Å) 10±1 9±1 8±1 9±1
2×tt (Å) 28±1 26±1 23±1 21±1
fh 0.5±0.1 0.4±0.1 0.4±0.1 0.4±0.1
ft 0.00±0.05 0.00±0.05 0.05±0.05 0.05±0.05
σh inner (Å) 2±1 2±1 2±1 2±1
σh outer (Å) 2±1 2±1 2±1 2±1
σt (Å) 2±1 2±1 2±1 2±1
fph n.a. 0 0 0
fpt n.a. 0.09±0.02 0.11±0.03 0.13±0.05
Npt/Nl n.a. 0.07±0.02 0.09±0.02 0.10±0.04
Fig. 3. Decrease in the thickness of the hydrophobic region of the bilayer caused by the
addition of increasing GAIV concentration, as determined by the neutron reﬂectivity ex-
periments. For comparison, the length of a GAIV helix is shown as a horizontal dotted line.
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peptide volume fraction fpt, and from the molecular volumes of
GAIV and of the lipid tails we could evaluate the inserted peptide to
lipid ratio at the different concentrations (Npt/Nl), which goes from
7% at C1 to 10% at C3. Unfortunately, within the experimental accura-
cy, it was not possible to distinguish whether the peptide molecules
are located in a speciﬁc part of the tail region or with a speciﬁc orien-
tation with respect to the bilayer normal z.
The second important information arising from the modeling is
that the inclusion of the peptide produces a thinning of the bilayer,
especially because of a thickness decrease of the tail region. Actually,
within the experimental accuracy, the headgroup thickness th is sta-
ble at all concentrations, while a decrease is observed in the tt param-
eter (tt is the thickness of the hydrophobic region of a single leaﬂet).
The overall hydrophobic region is “compressed” by ~7 Å going from
the pure lipid system to that with the highest amount of peptide in-
cluded. This thinning affects the overall bilayer thickness, decreasing
form 48±3 Å to 39±3 Å (Fig. 3). All of these structural changes are
detectable also from a comparison of the SLD proﬁles, as shown in
Fig. 2.
3.5. MD simulations
In order to understand at the molecular level the structural changes
observed in the bilayer in the NR experiments, we performed MD sim-
ulations of GAIV-membrane systems. In a previous computational study
[10] we showed that when GAIV is associated to themembrane parallel
to its surface it does not cause any signiﬁcant bilayer perturbation.
Therefore, in the present study we investigated the stability of a trans-
membrane peptide orientation and its effects on the bilayer.
3.6. Protocol for peptide insertion in the membrane
Due to the shortness of the trichogin chain, we devised a novel
approach for peptide insertion in a pre-equilibrated membrane. Pre-
viously reported methods of peptide/protein insertion in a membrane
involve bilayer assembly around the molecule either by packing the
lipids one by one, or by initially placing the lipids on a widely spaced
grid and then ‘shrinking’ the grid until the bilayer has the desired
density [65–67]. Other approaches involve formation of a pore that
spans the entire bilayer either by removing some lipids and/or by
using a repulsive potential [66–69]. However, when the molecule to
be inserted is signiﬁcantly shorter than the bilayer thickness (like
GAIV) and is to be placed in the hydrophobic core of the membrane,
these approaches would initially leave a part of the hydrophobic re-
gion of the bilayer exposed to water, i.e. a signiﬁcantly unstable and
unrealistic situation, and would require considerable equilibration
times.
To avoid these problems, we developed a way to create a peptide-
shaped cavity in the hydrophobic core of the membrane: peptide mole-
culeswere inserted in themiddle of thebilayer,with all their interactionsinitially switched off. Their van der Waals potential was then gradually
increased, up to the values of the simulation force ﬁeld (see Section 2
for a detailed description of the procedure). In this way, cavities were
formed, since the lipid chains were pushed out of the volume occupied
by the peptide molecules (Fig. S2).
Other methods were previously reported to form a protein-shaped
cavity similarly to our technique, but using more sophisticated ap-
proaches [70,71]. However, these methods often require manual inter-
vention, because they involve several input parameters and no standard
setting works for every system [72]. In addition, all of the methods
presently available encounter further difﬁculties in cases where many
copies of the same (small) molecule have to be inserted at different
positions in the bilayer. For this kind of targets, the method presented
here seems to be more suitable. In addition, since it does not require
any speciﬁc software nor modiﬁcation of complex codes, it is deﬁnitely
simpler.
3.7. MD trajectories
AfterGAIV insertion in these cavities and an appropriate 10 ns equil-
ibration period (during which the peptide was position-restrained),
these simulations were continued for 100 ns more. We performed a
total of 7 simulations: in one of them, only one peptide molecule was
inserted in the bilayer (comprising 128 POPC lipid molecules), in
three other simulations 4 GAIV molecules were inserted, and in further
three simulations the peptides in the bilayer were 8 (see Fig. S3, and
Section 2).
In most cases, the GAIV molecules maintained a transmembrane
orientation for the whole trajectory, and quickly (i.e. in about 10–30 ns)
some lipid headgroups in the region above and below the peptide were
drawn deeper in themembrane, due to the interactionwith the free pep-
tide NH and CO groups at the two termini of the helices. A few structures
representative of the time-evolution of the simulations are shown in
Fig. 4, while the kinetics of peptide-induced bilayer thinning is reported
in Fig. S4, and the structures at the end of the simulations are illustrated
in Fig. 5.
To better deﬁne the interactions responsible for the observed bi-
layer deformation, we performed an analysis of the interactions of
the peptide NH and CO groups not involved in intramolecular
H-bonds, and of the OH group of the C-terminal amino alcohol, with
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limited to the trajectory segment following the formation of the bi-
layer thinning, i.e. from 30 ns onward (Fig. 6). As expected, the NH
groups at the N-terminus interact mainly with the oxygen atoms of
the phosphate and glycerol groups, while the C-terminal CO groups
were almost invariably associated with the quaternary ammonium
of the lipid choline group. The OH group of Lol interacts mostly with
the glycerol moiety. All three GAIV groups (NH, CO and OH) also in-
teract with water molecules. These data indicate that the bilayer de-
formation is driven by electrostatic and H-bonding interactions,
which are enhanced in the low-dielectric constant environment of
the hydrophobic membrane core. These interactions lead to thinning
by drawing phospholipid headgroups deep into the membrane, thus
inducing an increase in the number of gauche conformations in the
lipid tails, as shown by a progressive decrease in their order parame-
ters, as the number of peptides in the bilayer increases (Fig. S5).
To further conﬁrm the stability of the transmembrane state, we
extended by further 40 ns the simulation previously obtained by
using the “minimum bias approach”, whose equilibrated segment
was initially just 10 ns long. During this time, no signiﬁcant modiﬁca-
tion in the peptide location, nor in the bilayer structure in its sur-
roundings was observed (data not shown). The same system was
simulated at 350 K for 65 ns without any evidence of destabilization
of the transmembrane conformation.
Overall, these simulation strongly support the possibility of a
transmembrane orientation for GAIV and a signiﬁcant thinning effect
on the bilayer, so that the short peptide helix could span it from one
side to the other. However, it is important to note the limitations in-
herent in these computational results, which are mainly associated to
the relatively short time scale that can be simulated. For instance,
membrane-inserted GAIV molecules do not associate during our tra-
jectories, while previously reported experiments indicate that this
phenomenon does take place [31,33–35]. The lack of aggregation in
the simulations is most likely due to the slow lateral diffusion of
both lipids and peptides with respect to the length of the trajectories.
We also know from experiments that the surface-bound state is high-
ly favored for a monomeric GAIV molecule [35]. By contrast, the
membrane inserted peptides essentially maintain the initial trans-
membrane orientation in most of the simulations, although some of
the peptides move towards the bilayer surface in some of the trajec-
tories with eight GAIV molecules. Once more, this is likely due to
the limited length of the trajectories. Therefore, the present MD cal-
culations are biased by the initial conditions, in which the peptides
were placed in a monomeric, membrane-inserted transbilayer orien-
tation. As such, they cannot rule out by themselves the formation of
dimers with one GAIV molecule on top of the other to match the
length of the bilayer, as proposed by some authors [27,32]. However,
the spontaneous formation of a system with a transbilayer inserted
GAIV monomer in one of the self-assembly simulations previously
reported [10], and the stability of this orientation in all the calcula-
tions presented here, deﬁnitely indicate that this state, accompanied
by membrane thinning, represents at least a local minimum in the
free-energy surface. In any case, a comparison of the MD trajectories
with the experimental neutron data can be used to assess the reliabil-
ity of the picture provided by the computational results.Fig. 4. Time evolution of a MD trajectory with 4 GAIV molecules embedded in the bilayer
(including the 10 ns equilibration time). Phosphorus, nitrogen and oxygen atoms of phos-
pholipids are shown as gold, blue and red spheres, respectively,whilewater oxygen atoms
are colored in pink. The acyl chains of the phospholipids are omitted for the sake of clarity.
Peptides are represented as ribbons, with the N- and C-termini are colored in blue and
red, respectively. The nOct and Lol moieties are shown in a “stick” representation.
Fig. 5. Final structures in the simulations with 1, 4 or 8 GAIV molecules. The representations used are the same as those described in Fig. 3.
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Neutron SLD proﬁles can be calculated from the MD trajectory and
compared with the experimental data (Section 2). The SLD proﬁlescalculated from the MD simulations, assuming a deuterated peptide
and a hydrogenated membrane in heavy water are shown in Fig. S6.
However, in order to perform a meaningful comparison, it was neces-
sary to take into account the fact that in our experiments the lipid
Fig. 6. Statistics of the interactions of selected peptide groups during the equilibrated seg-
ments of the MD trajectories with 4 GAIV molecules (30–110 ns). For each trajectory
frame, the lipid or water atom closest to the different peptide groups (N-terminal NH,
C-terminal CO and amino alcohol OH) was identiﬁed.
Fig. 7. Comparison between the neutron SLD proﬁles calculated from the MD trajecto-
ries of a peptide-free POPC bilayer (black dotted line) and in the presence of 8 GAIV
molecules (gray dotted line, peptide to lipid ratio 0.0625) with the symmetrical proﬁles
obtained from the experimental neutron data of the peptide-free bilayer (black solid line)
and in the presence of deuterated GAIV at concentration C1 (gray solid line, estimated
inserted peptide to lipid ratio 0.07±0.02; see Table 2).
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water in the simulations. It was previously demonstrated that GAIV
very quickly partitions in both layers of the membrane [35], and this
should lead to a symmetrical SLD proﬁle for a GAIV-containing bilayer
in water. Therefore, the SLD proﬁle of a free-standing membrane was
obtained from the experimental proﬁles by reﬂecting the section of
the proﬁle corresponding to thewater-facing side of the bilayerwith re-
spect to the center of the hydrophobic region. The comparison of the
resulting proﬁles, reported in Fig. 7, shows a good qualitative agree-
ment, regarding both the thickness of the bilayer and the increase in
SLD due to GAIV insertion in the membrane. This comparison confers
a good conﬁdence to the atomic-level picture provided by the MD
simulations.3.9. Vesicle leakage experiments
Both the simulations and the neutron reﬂectivity experiments indi-
cate the possibility for GAIV to span the bilayer entirely, by causing a sig-
niﬁcant thinning of the membrane. However, this bilayer deformation
requires a free energy cost. Therefore, if a transmembrane orientation
is involved in the GAIV pore-formation process, the membrane-
perturbing activity of this peptide should increase signiﬁcantly in thin-
ner membranes, which require a smaller deformation or no thinning
at all. To verify this point, we performedpeptide-induced vesicle leakage
experiments with liposomes formed by lipids with different chain
lengths and bilayer thicknesses [73]. For comparison, the same experi-
ments were carried out also with the much longer peptaibol Alm. As
shown in Figs. 8 and 9, the activity of GAIV increases dramatically with
decreasing the bilayer thickness, while that of Alm is affected only mar-
ginally. In bilayers with a thickness comparable to that of biological
membranes, the activity of GAIV is much lower than that of Alm
(Fig. 9). However, in the thinner membranes (whose hydrophobic core
has a size comparable to that of the GAIV helix), the activity of the two
peptides become comparable. It is also worth mentioning that the
curves of peptide-induced leakage as a function of GAIV concentration
(Fig. 8) are steeply sigmoidal in membranes with high thickness, indi-
cating a strong cooperativity of the pore formation process, but this
cooperativity decreases drastically in thinner membranes.4. Discussion
Both ourNR data andMD simulations showaGAIV-induced thinning
of themembrane. The effect of the insertion of a peptide/protein in a bi-
layer with an equilibrium hydrophobic thickness differing from that of
the inclusion has been rationalized in terms of hydrophobic mismatch
[74,75]. The free energy cost of exposing to water hydrophobic groups
of the protein or lipids, due to their different thickness, is higher than
that of distorting the lipids from their equilibrium conformation. As a
consequence, the membrane thickness locally adapts to the size of the
inclusion, although other effects are also possible [76]. The case of
GAIV falls under the category termed negative mismatch, where the in-
clusion is shorter than the membrane thickness. A systematic study on
model peptides demonstrated that hydrophobic mismatch is sufﬁcient
to drive membrane thickness adjustments comparable to those that
would be necessary for barrel-stave pore formation by GAIV [77]. How-
ever, our MD results indicate that, in the case of GAIV, membrane thin-
ning might be driven also by speciﬁc interactions between the peptide
N- and C-termini and the phospholipid headgroups. In this respect, it
is important to note that we have previously shown that in solvents of
low polarity GAIV binds cations with a very high afﬁnity [39]. This result
might reﬂect what is happening in the interaction between the peptide
and lipid headgroups in the low dielectric environment of the bilayer
core.
A completely different interpretation for peptide-induced mem-
brane thinning has been provided by Huang [78], and used to describe
the mechanism of action of both cationic AMPs and peptaibiotics.
According to his model, binding of an amphipathic molecule to the bi-
layer surface at the water–lipid chain interface leads to an increase in
the interfacial area, and thus to a decrease in the hydrocarbon thickness,
due to the very low volume compressibility of the lipid chains. This de-
formation has an elastic energy penalty, and thus, at a threshold bound
peptide concentration, a transmembrane orientation becomes favored.
In this model, membrane thinning is due to the surface-bound peptide,
rather than to the transmembrane-inserted molecules. Unfortunately,
we have previously shown that in both orientations GAIV is located
essentially in the hydrophobic core of the membrane [10,34,35] and
therefore the NR data do not allow us to discriminate between the
Huang hypothesis and thinning due to transmembrane inserted
Fig. 8. Peptide-induced vesicle leakage 20 min after addition of different concentration
of Alm (panel A) or GAIV (panel B), in bilayers of different thicknesses (lipid concentration
200 μM, vesicle diameter 200 nm). Red di22:1 PC (1,2-dierucoyl-sn-glycero-3-
phosphocholine); orange di20:1 PC (1,2-dieicosenoyl-sn-glycero-3-phosphocholine);
green di18:1 PC (1,2-dioleoyl-sn-glycero-3-phosphocholine); blue di16:1 PC (1,2-
dipalmitoleoyl-sn-glycero-3-phosphocholine); and violet di14:1 PC (1,2-dimyristoleoyl-
sn-glycero-3-phosphocholine).
Fig. 9. Membrane-permeabilizing peptide activity as a function of the hydrophobic
thickness of the bilayer [69]. The peptide concentration required to induce the leakage
of 50% of liposome contents (lipid concentration 200 μM, vesicle diameter 200 nm)
in 20 min was calculated from the leakage curves reported in Fig. 8, and is shown for
Alm (empty symbols) and GAIV (solid symbols).
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nism is unlikely for GAIV: insertion of this highly hydrophobic peptide
in the phospholipid tail region, parallel to the membrane surface, can
be easily accommodated, without causing a signiﬁcant increase in the
interfacial area nor a perturbation of membrane order, as also shown
by previous simulations and experiments performed by our group [10].
Whatever the driving force of the GAIV-induced membrane thin-
ning might be, this effect makes possible for the peptide to span the
bilayer from one side to the other, and also provides a rationalization
to a series of experimental observations regarding this peptaibol. Our
ﬂuorescence experiments demonstrated thatmembrane-inserted GAIV
exists essentially in an aggregate state [34,35]. Clearly, the free energycost of membrane deformation can be signiﬁcantly reduced by peptide
aggregation (just like in the hydrophobic effect aggregation of apolar
molecules in water reduces the entropic cost of water structuring
around them). Therefore, a monomeric transmembrane mismatched
inclusion is signiﬁcantly unstable [76]. This is probably themain driving
force for the highly cooperative GAIV oligomerization in membrane-
permeabilizing channels. This interpretation would also explain the
observation that curves of membrane-perturbing activity as a function
of GAIV concentration are highly cooperative in thick membranes,
while this cooperativity decreases signiﬁcantly in thinner membranes
(Fig. 8). The strong dependence of GAIV activity on membrane thick-
ness observed here is another evidence which can be easily explained
as due to the degree of membrane thinning necessary for this peptide
to span the whole bilayer. The observation that, on the other hand,
Alm activity is not very sensitive to the thickness of the bilayer is consis-
tent with previous studies on model peptides, which show that long
peptides can easily adapt to insertion in a thinner membrane by tilting
[79]. In principle, a large difference in GAIV activity between thin and
thick membranes could be also due to a transition from a barrel-stave
pore formed by a single GAIV layer to a “double barrel” of trichogin
dimers [27,32]. However, the membrane thinning observed in the NR
experiments is an indication contrasting this interpretation, at least in
the POPC bilayers used in those measurements, which have a thickness
comparable to natural membranes.
Alm is one of the longest peptaibiotics, but many “medium”- or
“short”-length peptides of this class do exist [11,80]. Therefore, the
present ﬁndings might be relevant for a rather wide class of peptides.
Longer peptaibols are much more active than shorter ones [81], but
barrel-stave channel formation has been hypothesized for some of the
latter, like the 16 residue long antiamoebin [82]. Solid-state NMRmea-
surements have also shown that such relatively short peptides, like the
14 residue ampullosporin or the 15 residue zervamicin II, attain a pre-
dominantly transmembrane orientationwhen themembrane thickness
is comparable to their length, while they are largely parallel to the sur-
face in thicker bilayers [83,84]. Therefore, it has been proposed that all
peptaibiotics might act according to the barrel-stave mechanism, the
lower activity of the shorter ones being due to the lowest fraction of
peptide molecules in a transmembrane orientation [84].
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possibility for a peptaibiotic to form barrel-stave channels in a mem-
brane thicker than its length. For instance, Alm is able to form pores
even in artiﬁcial membranes formed by diblock copolymers whose hy-
drophobic region is much thicker than the peptide length [85], thus
paralleling the situation of GAIV in biological membranes. In addition,
our ﬁndings regarding the membrane thickness dependence of GAIV
activity nicely parallel the observation that in a series of short-chain
GAIV analogs the activity signiﬁcantly and progressively decreased
with the shortening of the peptide chain [86].
No electrophysiology measurements of the conductance of single
GAIV channels in planarmembranes, whichwould provide a conclusive
conﬁrmation of a barrel-stave mechanism, have been reported to date.
However, experiments on liposomes have shown that the pores formed
by this peptide are ion selective and that their conductance is
voltage-dependent, as it would be expected for Alm-like barrel-stave
pores [44]. The voltage-gated nature of the GAIV channels was recently
conﬁrmed also by electrochemical measurements on Hg-supported
tethered bilayer lipid membranes [42].
Overall, the present data indicate that formation of transmem-
brane barrel-stave channels might indeed be possible even for short
peptaibiotics.
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